MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.abb.2026.110748

Медицинская библиотека · Archives of biochemistry and biophysics · 2026

Dexmedetomidine attenuates hyperoxia-induced lung injury in BPD mice via regulation of the mitophagy-NLRP3-pyroptosis pathway.

Feng Yue, Chen Dong-Zhui, Cai Heng, Zhang Qiu-Yue

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

Bronchopulmonary dysplasia (BPD) is a common chronic lung disease in preterm infants. Although dexmedetomidine (Dex) has been shown to exert lung-protective effects in experimental BPD models, the underlying molecular mechanisms remain incompletely understood. This study aimed to investigate whether Dex confers protection against hyperoxia-induced lung injury through regulation of the mitophagy-NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome-pyroptosis axis.

METHODS

A neonatal mouse model of BPD and a hyperoxia-induced injury model in primary alveolar type II epithelial (AECII) cells were established. Gain- and loss-of-function approaches targeting PINK1/Parkin-mediated mitophagy and NLRP3 were applied. Mitophagy, inflammasome activation, mitochondrial integrity, inflammatory responses, and cell injury were evaluated using molecular, imaging, and functional assays.

RESULTS

Dex significantly alleviated hyperoxia-induced lung injury in neonatal mice and improved the survival of AECII cells under oxidative stress. Dex treatment enhanced PINK1/Parkin-mediated mitophagy, preserved mitochondrial structure and function, suppressed NLRP3 inflammasome activation, reduced inflammatory cytokine release, and attenuated pyroptosis-related protein expression. Notably, genetic silencing of PINK1 abolished the protective effects of Dex, while NLRP3 overexpression partially reversed Dex-mediated anti-inflammatory and cytoprotective effects, indicating a mechanistic link between mitophagy activation and inflammasome inhibition.

CONCLUSION

Dex protects against hyperoxia-induced lung injury by activating PINK1/Parkin-dependent mitophagy, maintaining mitochondrial homeostasis, inhibiting NLRP3 inflammasome activation, and suppressing pyroptosis. These findings provide mechanistic insight into the therapeutic potential of Dex for the prevention and treatment of BPD.

Для цитирования: Feng Yue, Chen Dong-Zhui, Cai Heng, Zhang Qiu-Yue. Dexmedetomidine attenuates hyperoxia-induced lung injury in BPD mice via regulation of the mitophagy-NLRP3-pyroptosis pathway.. Archives of biochemistry and biophysics. 2026. DOI: 10.1016/j.abb.2026.110748.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.